14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
PSQH vs PRZO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, PSQ Holdings, Inc. (PSQH) is the stronger overall head-to-head candidate over ParaZero Technologies Ltd. (PRZO) in the Tradestie Institutional Equity Comparison Engine, winning 2–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PSQH carries a Unified Composite Score of 40.1/100 (SELL) at $1.68 (N/M Forward P/E, -45.3% operating margin), whereas PRZO carries 41.1/100 (SELL) at $0.29 (N/M Forward P/E, -452.7% operating margin).
Composite vs. Pillar Nuance: While PRZO currently prints a higher short-term Unified Composite Score (41.1/100 SELL vs. PSQH 40.1/100 SELL), PSQH captures the overall institutional head-to-head verdict (2–5 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-45.3% vs. -452.7% operating margin) and revenue trajectory (+66.7% vs. +195.3% YoY).
Defensive Composite Rating Caution: Although PSQH compares more favorably head-to-head, both PSQH (40.1/100 SELL) and PRZO (41.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: PSQH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.4); meanwhile PRZO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PSQH vs PRZO. Trailing 12-month operating profitability (PSQH -45.3% vs PRZO -452.7%) and valuation multiples (PSQH N/M vs PRZO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Aerospace & Defense value chain with $10.3M market capitalization and -452.7% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ PSQH vs PRZO Key Questions & Quantitative Answers
As of Nov 20, 2026, PSQ Holdings, Inc. (PSQH) is the stronger overall head-to-head candidate over ParaZero Technologies Ltd. (PRZO) in the Tradestie Institutional Equity Comparison Engine, winning 2–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PSQH carries a Unified Composite Score of 40.1/100 (SELL) at $1.68 (N/M Forward P/E, -45.3% operating margin), whereas PRZO carries 41.1/100 (SELL) at $0.29 (N/M Forward P/E, -452.7% operating margin). Composite vs. Pillar Nuance: While PRZO currently prints a higher short-term Unified Composite Score (41.1/100 SELL vs. PSQH 40.1/100 SELL), PSQH captures the overall institutional head-to-head verdict (2–5 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (-45.3% vs. -452.7% operating margin) and revenue trajectory (+66.7% vs. +195.3% YoY). Defensive Composite Rating Caution: Although PSQH compares more favorably head-to-head, both PSQH (40.1/100 SELL) and PRZO (41.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: PSQH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.4); meanwhile PRZO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PRZO leads the Growth & Scale pillar: PSQH posts +66.7% YoY revenue growth and +0.0% YoY earnings growth on $30M TTM revenue (58.0% gross margin, -45.3% operating margin), compared with PRZO at +195.3% YoY revenue growth and +0.0% YoY earnings growth on $1.7M TTM revenue (28.9% gross margin, -452.7% operating margin). On trailing 12-month operating scale, PSQH generates $30M in USD-normalized revenue versus $1.7M for PRZO. In operating R&D and SG&A reinvestment, PSQH deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PRZO.
PSQH screens cheaper on headline valuation multiples. PSQH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.3x EV/Revenue (-42.7% FCF margin), whereas PRZO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 5.9x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PSQH (-277.8% ROE) versus PRZO (-134.8% ROE) capital efficiency.
In options market volatility and institutional positioning, PSQH carries 165.0% implied volatility (21st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (-3.65β · 157% Vol realized risk). By comparison, PRZO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.42β · 68% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.